Search

everythinglearnresearchcommunity

for

Search:↓

Some patients fail bladder function tests due to lower flow rates and higher remaining urine volumes, but the exact reasons for failure are unclear.

Stauntonia hexaphylla extract can help treat hair loss by blocking certain hormones.

HFMs can help study hair growth and test potential hair growth drugs.

Both mouse and rat models are effective for testing alopecia areata treatments.

Many potential alopecia treatments need more testing to confirm they promote acceptable hair growth with minimal side effects.

The 2012 criteria are better for diagnosing atypical lupus cases.

The mouse models are effective for testing new hair loss treatments.

Early identification of lupus through skin signs and blood tests is crucial in India.

The new lab-grown skin model is good for testing sunscreen's protection against DNA damage from UV light.

Scientists made a mouse model of a serious skin cancer by changing skin cells with a virus and a specific gene, which is similar to the disease in humans.

The TCL1 transgenic mouse model is useful for understanding human B-cell leukemia and testing new treatments.

Thermoresponsive nanogels show promise for delivering medicine through the skin but need more safety testing and regulatory approval before clinical use.

Scientists created a 3D skin model to study a chronic skin disease and test treatments.

Skin structure complexity and variability are crucial for assessing skin toxicity in safety tests.

Fat tissue stem cells show promise for repairing different body tissues and are being tested in clinical trials.

The created skin model with melanoblasts improves the study of skin color and offers an alternative to animal testing.

Human hair follicle organ culture is a useful model for hair research with potential for studying hair biology and testing treatments.

AIRE-deficient rats developed severe autoimmune disease similar to APECED, useful for testing treatments.

Skin reactions to drugs are common and can be deadly, usually requiring stopping the drug and may be better prevented with genetic testing in the future.

Many treatments for hair loss show potential, but more testing is needed to confirm their effectiveness. Only minoxidil for women and minoxidil and finasteride for men are FDA approved.

Cepharanthine, a Japanese hair loss drug, shows promise as a COVID-19 treatment but needs more testing.

The document explains the difficulty in diagnosing and treating brain diseases caused by the immune system and stresses the need for quick and accurate tests.

All medications can cause skin rashes, often without a clear cause, and better tests are needed to identify these drug-related skin issues.

Biopsy can differentiate between alopecia areata and androgenic alopecia, and if more information is needed, testing for CD3 and CD8 can help.

The conclusion is that we need more effective hair loss treatments than the current ones, and these could include new drugs, gene and stem cell therapy, hormones, and scalp cooling, but they all need thorough safety testing.

Hormonal treatments can help with hair loss, acne, and excess hair growth, but it takes 3-6 months to see results and patients should know the possible side effects.

Finasteride helps regrow hair and shrink prostate by reducing DHT, with some sexual side effects.

Effective hair loss treatment in women requires correct diagnosis and can include medications like minoxidil, antiandrogens, and treatments for underlying conditions like PCOS.

A 16-year-old boy with Castleman's disease and lupus was successfully treated and showed no recurrence.

A man with Klinefelter syndrome had a leg ulcer that didn't heal well, even with treatment.